Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

by David S. Mathiesen, Asger Lund, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jonatan I. Bagger, Jonatan I. Bagger
Published 2021-01-01

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

by Marta Seghieri, Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll
Published 2018-11-01

Hypoglycaemia and cardiac arrhythmias in diabetes

by Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll
Published 2020-05-01

Glucagon Receptor Signaling and Lipid Metabolism

by Katrine D. Galsgaard, Katrine D. Galsgaard, Jens Pedersen, Jens Pedersen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jens J. Holst, Jens J. Holst, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen
Published 2019-04-01

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review

by Katrine B Hansen, Tina Vilsbøll, Filip K Knop
Published 2010-05-01

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral...

by Robert Eriksson, Robert Eriksson, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Niklas R. Jørgensen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Bjørn H. Ebdrup
Published 2019-01-01

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

by Kristian H. Mikkelsen, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Filip K. Knop, Morten Frost
Published 2018-09-01

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

by Andrea Mari, Jonatan I Bagger, Ele Ferrannini, Jens J Holst, Filip K Knop, Tina Vilsbøll
Published 2013-01-01

Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

by Benjamin Guiastrennec, David P. Sonne, Martin Bergstrand, Tina Vilsbøll, Filip K. Knop, Mats O. Karlsson
Published 2018-09-01

Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives

by Klara Coello, Maj Vinberg, Filip K. Knop, Bente K. Pedersen, Roger S. McIntyre, Lars V. Kessing, Klaus Munkholm
Published 2019-04-01

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review

by David S. Mathiesen, Jonatan I. Bagger, Natasha C. Bergmann, Asger Lund, Mikkel B. Christensen, Tina Vilsbøll, Filip K. Knop
Published 2019-08-01

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

by Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll
Published 2016-01-01

Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

by Birgitte B. Bennich, Michael E. Røder, Dorthe Overgaard, Ingrid Egerod, Lene Munch, Filip K. Knop, Tina Vilsbøll, Hanne Konradsen
Published 2017-07-01

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion

by Nicolai J. Wewer Albrechtsen, Simon Veedfald, Astrid Plamboeck, Carolyn F. Deacon, Bolette Hartmann, Filip K. Knop, Tina Vilsboll, Jens J. Holst
Published 2016-01-01

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and with...

by Amelia K. Fotheringham, Jonatan I. Bagger, Danielle J. Borg, Domenica A. McCarthy, Jens J. Holst, Tina Vilsbøll, Filip K. Knop, Josephine M. Forbes
Published 2020-09-01

Glucagon Receptor Signaling and Glucagon Resistance

by Lina Janah, Sasha Kjeldsen, Katrine D. Galsgaard, Marie Winther-Sørensen, Elena Stojanovska, Jens Pedersen, Filip K. Knop, Jens J. Holst, Nicolai J. Wewer Albrechtsen
Published 2019-07-01

Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites

by Annieke C G van Baar, Andrei Prodan, Camilla D Wahlgren, Steen S Poulsen, Filip K Knop, Albert K Groen, Jacques J Bergman, Max Nieuwdorp, Evgeni Levin
Published 2018-05-01

Gluco-metabolic effects of oral and intravenous alcohol administration in men

by Amalie R Lanng, Lærke S Gasbjerg, Natasha C Bergmann, Sigrid Bergmann, Mads M Helsted, Matthew P Gillum, Bolette Hartmann, Jens J Holst, Tina Vilsbøll, Filip K Knop
Published 2019-10-01

INPP4B protects from metabolic syndrome and associated disorders

by Manqi Zhang, Yasemin Ceyhan, Elena M. Kaftanovskaya, Judy L. Vasquez, Jean Vacher, Filip K. Knop, Lubov Nathanson, Alexander I. Agoulnik, Michael M. Ittmann, Irina U. Agoulnik
Published 2021-03-01

Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism.

by Kristian H Mikkelsen, Morten Frost, Martin I Bahl, Tine R Licht, Ulrich S Jensen, Jacob Rosenberg, Oluf Pedersen, Torben Hansen, Jens F Rehfeld, Jens J Holst, Tina Vilsbøll, Filip K Knop
Published 2015-01-01